您的位置: 首页 > 农业专利 > 详情页

DERIVADO DE 2-ACILAMINOTIAZOLE PARA UTILIZAÇÃO NA PREVENÇÃO OU TRATAMENTO DE DOENÇAS DA BEXIGA/TRATO URINÁRIO
专利权人:
ASTELLAS PHARMA INC.
发明人:
TAKANORI KOIKE,JUN MAEDA,KAZUHIRO YOKOYAMA,HIROAKI TANAKA,TAISUKE TAKAHASHI,KENJI NEGORO,HAJIME TAKAMATSU
申请号:
PT15803484
公开号:
PT3153511T
申请日:
2015.06.05
申请国别(地区):
PT
年份:
2019
代理人:
摘要:
To provide a compound useful as an active ingredient of a pharmacological composition for the treatment of urinary storage symptoms, dysuria, lower urinary tract diseases, and the like. [Solution] The inventors perfected the present invention after discovering that thiazole derivatives substituted at position 2 by pyrazinylcarbonylamino are exceptional muscarinic M 3 receptor positive allosteric modulators and can be expected to serve as agents for the prevention or treatment of urinary bladder and urinary tract diseases involving bladder contraction mediated by muscarinic M 3 receptors. The 2-acylaminothiazole derivatives or salts thereof of the present invention can be expected to serve as agents for the prevention or treatment of urinary bladder and urinary tract diseases involving bladder contraction mediated by muscarinic M 3 receptors, e.g., underactive bladder and the like.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充